
内科理论与实践››2025,Vol. 20››Issue (01): 76-80.doi:10.16138/j.1673-6087.2025.01.16
吴超1a, 庄蕾1b(
), 马君俊1a, 何子锐1a, 孙永顺2(
)
收稿日期:2024-10-29出版日期:2025-02-28发布日期:2025-04-30通讯作者:庄蕾 E-mail: zl11211@rjh.com.cn; 孙永顺 E-mail: 13764403043@163.com基金资助:
WU Chao1a, ZHUANG Lei1b(
), MA Junjun1a, HE Zirui1a, SUN Yongshun2(
)
Received:2024-10-29Online:2025-02-28Published:2025-04-30摘要:
虎杖苷是从传统中药材虎杖中提取的主要活性成分,具有抗炎、抗氧化和调节细胞凋亡等多种药理作用。其在肝病、炎症性肠病等消化系统疾病治疗中的应用研究逐渐受到关注。本文综述虎杖苷在消化系统(肝胆胰及胃肠道)良恶性疾病中的治疗进展,分析其潜在作用机制,以期为虎杖苷干预消化系统疾病的深入研究提供新思路。
中图分类号:
吴超, 庄蕾, 马君俊, 何子锐, 孙永顺. 虎杖苷在消化系统疾病治疗中的研究进展[J]. 内科理论与实践, 2025, 20(01): 76-80.
WU Chao, ZHUANG Lei, MA Junjun, HE Zirui, SUN Yongshun. Research progress of polydatin in treatment of digestive system diseases[J]. Journal of Internal Medicine Concepts & Practice, 2025, 20(01): 76-80.
| [1] | 梁春晓, 王珊珊, 陈淑静, 等. 虎杖化学成分及药理活性研究进展[J].中草药,2022,53(4):1264-1276. |
| [2] | 林思, 秦慧真, 邓玲玉, 等. 虎杖苷药理作用及机制研究进展[J].中国实验方剂学杂志,2021,27(22):241-250. |
| [3] | Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules[J].Sci Rep,2017,7:42717. |
| [4] | Xiong G, Wu Z, Yi J, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties[J].Nucleic Acids Res,2021,49(W1):W5-W14. |
| [5] | Zhao G, Yang L, Zhong W, et al. Polydatin, a glycoside of resveratrol, is better than resveratrol in alleviating non-alcoholic fatty liver disease in mice fed a high-fructose diet[J].Front Nutr,2022,9:857879. |
| [6] | Oliviero F, Zamudio-Cuevas Y, Belluzzi E, et al. Polydatin and resveratrol inhibit the inflammatory process induced by urate and pyrophosphate crystals in THP-1 cells[J].Foods,2019,8(11):560. |
| [7] | Karami A, Fakhri S, Kooshki L, et al. Polydatin: pharmacological mechanisms, therapeutic targets, biological activities, and health benefits[J].Molecules,2022,27(19):6474. |
| [8] | 何峰, 覃岭, 温祥臣. 虎杖苷对幽门螺旋杆菌脂多糖诱导的胃黏膜损伤大鼠胃黏膜细胞凋亡及TNF-α 水平影响[J].环球中医药,2018,11(9):1347-1351. |
| [9] | 杨惠玲, 武继军, 史建伟. 虎杖苷对烫伤大鼠胃肠黏膜的保护作用[J].亚太传统医药,2008,4(7):23-25. |
| [10] | 郑舜华. 中药胃黏膜保护的研究进展[J].中华消化杂志,2007,27(11):758-759. |
| [11] | Chen G, Yang Z, Wen D, et al. Polydatin has anti-inflammatory and antioxidant effects in LPS-induced macrophages and improves DSS-induced mice colitis[J].Immun Inflamm Dis,2021,9(3):959-970. |
| [12] | Lv T, Shen L, Yang L, et al. Polydatin ameliorates dextran sulfate sodium-induced colitis by decreasing oxidative stress and apoptosis partially via sonic hedgehog signaling pathway[J].Int Immunopharmacol,2018,64:256-263. |
| [13] | Liu B, Li S, Sui X, et al. Root extract ofPolygonum cuspidatum Siebold & Zucc.Ameliorates DSS-induced ulcerative colitis by affecting NF-kappaB signaling pathway in a mouse model via synergistic effects of polydatin, resveratrol, and emodin[J].Front Pharmacol,2018,9:347. |
| [14] | Peritore AF, D’Amico R, Cordaro M, et al. PEA/Polydatin: anti-inflammatory and antioxidant approach to counteract DNBS-induced colitis[J].Antioxidants (Basel),2021,10(3):464. |
| [15] | Liu YJ, Xu WH, Fan LM, et al. Polydatin alleviates DSS- and TNBS-induced colitis by suppressing Th17 cell differentiation via directly inhibiting STAT3[J].Phytother Res,2022,36(9):3662-3671. |
| [16] | Ebrahim HA, Elsherbini DMA. Renovation of intestinal barrier by polydatin in experimentally induced ulcerative colitis: comparative ultrastructural study with l-carnosine[J].Cells Tissues Organs,2021,210(4):275-292. |
| [17] | Yousef AI, Shawki HH, El-Shahawy AA, et al. Polydatin mitigates pancreatic β-cell damage through its antioxidant activity[J].Biomed Pharmacother,2021,133:111027. |
| [18] | 于晓鹏.超高效液相色谱-质谱法对结石患者胆汁的代谢组学鉴定结果探讨与虎杖苷对胆固醇结石形成的影响和机制研究[D]. 沈阳: 中国医科大学,2023. |
| [19] | Chen X, Chan H, Zhang L, et al. The phytochemical polydatin ameliorates non-alcoholic steatohepatitis by restoring lysosomal function and autophagic flux[J].J Cell Mol Med,2019,23(6):4290-4300. doi:10.1111/jcmm.14320pmid:30973211 |
| [20] | Lai Y, Zhou C, Huang P, et al. Polydatin alleviated alcoholic liver injury in zebrafish larvae through ameliorating lipid metabolism and oxidative stress[J].J Pharmacol Sci,2018,138(1):46-53. doi:S1347-8613(18)30156-7pmid:30245287 |
| [21] | Liu YH, Huang QH, Wu X, et al. Polydatin protects against acetaminophen-induced hepatotoxicity in mice via anti-oxidative and anti-apoptotic activities[J].Food Funct,2018,9(11):5891-5902. |
| [22] | Liu C, Wang W, Zhang K, et ak. Protective effects of polydatin from grapes andReynoutria japonicahoutt. on damaged macrophages treated with acetaminophen[J].Nutrients,2022,14(10):2077. |
| [23] | Cheng K, Niu J, Zheng X, et al. Aflatoxin-B1-exposure-induced hepatic injury could be alleviated by polydatin through reducing oxidative stress, inhibiting inflammation and improving mitophagy[J].Toxics,2023,11(4):309. |
| [24] | Tang D, Zhang Q, Duan H, et al. Polydatin: a critical promising natural agent for liver protection via antioxidative stress[J].Oxid Med Cell Longev,2022,2022:9218738. |
| [25] | Yan C, Hu W, Tu J, et al. Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease[J].J Transl Med,2023,21(1):300. doi:10.1186/s12967-023-04166-8pmid:37143126 |
| [26] | Wong VW, Ekstedt M, Wong GL, et al. Changing epidemiology, global trends and implications for outcomes of NAFLD[J].J Hepatol,2023,79(3):842-852. doi:10.1016/j.jhep.2023.04.036pmid:37169151 |
| [27] | He J, Qian YC, Yin YC, et al. Polydatin: a potential NAFLD therapeutic drug that regulates mitochondrial autophagy through SIRT3-FOXO3-BNIP3 and PINK1-PRKN mechanisms - a network pharmacology and experimental investigation[J].Chem Biol Interact,2024,398:111110. |
| [28] | Li R, Li J, Huang Y, et al. Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice[J].Int J Biol Sci,2018,14(11):1411-1425. |
| [29] | Koneru M, Sahu BD, Gudem S, et al. Polydatin alleviates alcohol-induced acute liver injury in mice: relevance of matrix metalloproteinases (MMPs) and hepatic antioxidants[J].Phytomedicine,2017,27:23-32. |
| [30] | Chen Y, Li Y, Jia P, et al. Polydatin attenuates intra-uterine growth retardation-induced liver injury and mitochondrial dysfunction in weanling piglets by improving energy metabolism and redox balance[J].Antioxidants (Basel),2022,11(4):666. |
| [31] | Lin L, Gong H, Li R, et al. Nanodrug with ROS and pH dual-sensitivity ameliorates liver fibrosis via multicellular regulation[J].Adv Sci (Weinh),2020,7(7):1903138. |
| [32] | Lan T, Zhuang L, Li S, et al. Polydatin attenuates hepatic stellate cell proliferation and liver fibrosis by suppressing sphingosine kinase 1[J].Biomed Pharmacother,2020,130:110586. |
| [33] | Zhao X, Yang Y, Yu H, et al. Polydatin inhibits ZEB1-invoked epithelial-mesenchymal transition in fructose-induced liver fibrosis[J].J Cell Mol Med,2020,24(22):13208-13222. doi:10.1111/jcmm.15933pmid:33058500 |
| [34] | Bao HL, Chen CZ, Ren CZ, et al. Polydatin ameliorates hepatic ischemia-reperfusion injury by modulating macrophage polarization[J].Hepatobiliary Pancreat Dis Int,2024,23(1):25-34. |
| [35] | Chen Q, Shu C, Laurence AD, et al. Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial[J].Gut,2018,67(11):2006-2016. doi:10.1136/gutjnl-2018-315983pmid:29802174 |
| [36] | Cabibbo G, Celsa C, Rimassa L, et al. Navigating the landscape of liver cancer management: study designs in clinical trials and clinical practice[J].J Hepatol,2024,80(6):957-966. |
| [37] | Jiao Y, Wu Y, Du D. Polydatin inhibits cell proliferation, invasion and migration, and induces cell apoptosis in hepatocellular carcinoma[J].Braz J Med Biol Res,2018,51(4):e6867. |
| [38] | Jiang J, Chen Y, Dong T, et al. Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3-FOXO1 signaling pathway[J].Oncol Lett,2019,17(5):4505-4513. doi:10.3892/ol.2019.10123pmid:30944640 |
| [39] | Farooq U, Wang H, Hu J, et al. Polydatin inhibits hepatocellular carcinoma cell proliferation and sensitizes doxorubicin and cisplatin through targeting cell mitotic machinery[J].Cells,2023,12(2):222. |
| [40] | Eng C, Yoshino T, Ruíz-García E, et al. Colorectal cancer[J].Lancet,2024,404(10449):294-310. |
| [41] | De Maria S, Scognamiglio I, Lombardi A, et al. Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell[J].J Transl Med,2013,11:264. |
| [42] | Jin Y, Zhan X, Zhang B, et al. Polydatin exerts an antitumor effect through regulating the miR-382/PD-L1 axis in colorectal cancer[J].Cancer Biother Radiopharm,2020,35(2):83-91. |
| [43] | Zhou S, Sun Y, Wang K, et al. Polyvinylpyrrolidone-polydatin nanoparticles protect against oxaliplatin induced intestinal toxicityin vitroandin vivo[J].Food Chem Toxicol,2024,184:114427. |
| [44] | Bae H, Lee W, Song J, et al. Polydatin counteracts 5-fluorouracil resistance by enhancing apoptosis via calcium influx in colon cancer[J].Antioxidants (Basel),2021,10(9):1477. |
| [45] | Chen Q, Zeng YN, Zhang K, et al. Polydatin increases radiosensitivity by inducing apoptosis of stem cells in colorectal cancer[J].Int J Biol Sci,2019,15(2):430-440. doi:10.7150/ijbs.27050pmid:30745832 |
| [46] | De Gregorio A, Krasnowska EK, Zonfrillo M, et al. Influence of polydatin on the tumor microenvironment in vitro: studies with a colon cancer cell model[J].Int J Mol Sci,2022,23(15):8442. |
| [47] | 张翠翠, 李强. 虎杖苷通过蛋白激酶B信号通路影响胃癌细胞增殖凋亡[J].安徽医药,2021,25(9):1708-1712. |
| [48] | 肖永琴, 张珂, 曹静平. 虎杖苷通过抑制miR-301a促进胃癌SGC-7901细胞凋亡的机制研究[J].中医药导报,2021,27(6):63-67. |
| [49] | 祝金华, 赵士梅, 马秀岩, 等. 虎杖苷调节Akt/MDM2/p53信号通路对胆囊癌细胞增殖、迁移和细胞周期的影响[J].河北医药,2024,46(6):835-839. |
| [50] | Liu K, Liu J, Xu A, et al. The role of polydatin in inhibiting oxidative stress through SIRT1 activation: a comprehensive review of molecular targets[J].J Ethnopharmacol,2024,331:118322. |
| [1] | 木卡大斯·热合曼, 蒋婕, 童建菁.咖啡对消化系统恶性肿瘤影响的研究进展[J]. 内科理论与实践, 2023, 18(05): 368-371. |
| [2] | 李响, 王杨, 葛晓利, 潘曙明.中药虎杖治疗脓毒症的研究进展[J]. 内科理论与实践, 2022, 17(01): 92-96. |
| [3] | 王婷, 袁菲, 王朝夫.2019年《世界卫生组织消化系统肿瘤分类》(第5版)胰腺上皮性肿瘤解读[J]. 诊断学理论与实践, 2020, 19(06): 559-564. |
| [4] | 罗茜, 曹伟新, 施咏梅,.消化系统恶性肿瘤病人营养状况与生活质量评价[J]. 外科理论与实践, 2016, 21(01): 44-48. |
| [5] | 王志威, 于颖彦,.ABO血型与消化系统肿瘤发生发展的关系[J]. 诊断学理论与实践, 2011, 10(06): 567-570. |
| [6] | 罗茜, 曹伟新, 吴蓓雯,.不同营养评价方法对消化系恶性肿瘤病人营养状况评价的意义[J]. 外科理论与实践, 2010, 15(04): 393-397. |
| [7] | 吴蓓雯, 曹伟新, 燕敏, 张俊,.主观综合营养评价法评判消化系统恶性肿瘤病人营养状况和预后[J]. 外科理论与实践, 2008, 13(05): 415-418. |
| [8] | 裘佳培, 燕敏, 姚学新, 王晓彦, 李琛, 陈军, 项明,.X线透视下放置螺旋型鼻肠管的操作体会[J]. 外科理论与实践, 2007, 12(03): 281-282. |
| [9] | 袁琼英, 刘菲, 莫剑忠,.硫化氢与消化系统[J]. 内科理论与实践, 2007, 2(02): 128-132. |
| [10] | 于世英,.晚期消化系肿瘤镇痛治疗新进展[J]. 外科理论与实践, 2006, 11(06): 489-491. |
| [11] | 冯波,郑民华.腹腔镜消化系恶性肿瘤手术进展[J]. 外科理论与实践, 2004, 9(06): 522-524. |
| [12] | 施健,刘苏,谢渭芬.囊性纤维化的消化系统表现[J]. 诊断学理论与实践, 2004, 3(05): 86-88. |
| [13] | 朱承谟.核医学在消化系统疾病中的应用[J]. 诊断学理论与实践, 2002, 1(03): 7-10. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||